Glatopa is a generic version of Copaxone® to treat relapsing-forms of multiple sclerosis

Glatopa has been approved by the FDA as a fully substitutable version of Copaxone® (glatiramer acetate injection). Now, you can get therapeutically equivalent treatment with less financial burden.

The medicine you expect, the support you deserve

Glatopa is an FDA-approved generic that can be substituted for Copaxone®.

  • Contains the same active ingredient
  • Offers the same dosage therapeutic effect
  • Is administered the same way (under the skin)
  • Backed by GlatopaCare patient support services

Glatopa and Copaxone equivalency chart

Glatopa and Copaxone equivalency chart

Whether you are switching to Glatopa from Copaxone®, or just getting started with glatiramer acetate, you can be sure you're receiving the same FDA-approved medicine found in Copaxone®.

Quality icon

Quality backed by knowledge

  • Glatopa meets rigorous FDA quality standards for production
  • Glatopa is made in the United States
  • Brought to you by Sandoz, a Novartis Division and one of the leading generic pharmaceutical companies in the world